Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Krishnan Viswanadhan

Chief Corp Dev & Strategy at Agios Pharmaceuticals, Inc. (AGIO)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $185K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 6SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 2,95910,282 held (−22%) $34.71 $103K -9.8%
Mar 9SEC AGIOAgios Pharmaceuticals, Inc. Sell Plan 2,9595,141 held (−37%) $27.80 $82K +12.7%
  • Sell

    Chief Corp Dev & Strategy Krishnan Viswanadhan sold $103K of AGIO at $34.71 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Corp Dev & Strategy Krishnan Viswanadhan sold $82K of AGIO at $27.80 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.